Skip to main content
GENINUS Inc. logo

GENINUS Inc. — Investor Relations & Filings

Ticker · 389030 ISIN · KR7389030008 KO Professional, scientific and technical activities
Open in API
Filings indexed 149 across all filing types
Latest filing 2026-03-05 Regulatory Filings
Country KR South Korea
Listing KO 389030

About GENINUS Inc.

https://www.kr-geninus.com/

GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.

Recent filings

Filing Released Lang Actions
[기재정정]금전대여결정 (대여기간 연장)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean DART system regarding a 'Decision on Money Lending' (금전대여결정) and a subsequent correction (정정신고). It details a loan extension to a subsidiary (GxD株式會社). Since this is a specific regulatory disclosure regarding corporate financing/lending activities that does not fit into the other specialized categories like M&A or Dividend announcements, it is classified as a Regulatory Filing (RNS).
2026-03-05 Korean
[기재정정]금전대여결정
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a 'Correction Report' (정정신고) for a 'Decision to Lend Money' (금전대여결정). It details the correction of equity calculations and provides specific terms of a loan to a subsidiary (GxD). Since this is a specific regulatory disclosure regarding corporate financing/lending activities that does not fit into the other specialized categories like M&A or Share Issues, it falls under the 'Regulatory Filings' category.
2026-03-05 Korean
[기재정정]파생상품거래손실발생
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a correction to a previously reported 'Loss from Derivatives Transaction'. It details the correction of equity calculations and provides specific financial data regarding derivative valuation losses. As this is a specific regulatory disclosure regarding financial events that does not fit into categories like Annual Reports, Earnings Releases, or M&A, it falls under the general regulatory filing category.
2026-03-04 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Geninus) regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It includes details about the meeting date, agenda items (such as financial statement approval, director appointments, and remuneration limits), and a correction notice for a previous filing. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on agenda items at the upcoming meeting.
2026-02-23 Korean
[기재정정]타인에대한채무보증결정
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증결정). It is a formal correction filing (정정신고) detailing financial guarantees provided to a subsidiary. Since it does not fit into specific categories like earnings, dividends, or M&A, and is a standard regulatory disclosure required by the Capital Markets Act, it falls under the 'Regulatory Filings' category.
2026-02-19 Korean
[기재정정]금전대여결정
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a 'Decision on Monetary Loan' (금전대여결정). It is a formal amendment (정정신고) to a previous disclosure, detailing the terms of a loan provided to a subsidiary (GxD). This type of disclosure regarding corporate financing and inter-company lending falls under the 'Regulatory Filings' category as it is a specific corporate action announcement that does not fit into the other specialized categories like M&A, Dividends, or Earnings Releases.
2026-02-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.